Low toenail chromium concentration and increased risk of nonfatal myocardial infarction

American Journal of Epidemiology

Volumn 162, Issue 2, 2005, Pages 157-164

  Guallar, Eliseo ^a,b,n   Jiménez, F Javier ^b,c   Van 't Veer, Pieter ^d   Bode, Peter ^e   Riemersma, Rudolph A ^f,g   Gómez Aracena, Jorge ^h,i   Kark, Jeremy D ^j,k   Arab, Lenore ^l   Kok, Frans J ^d   Martín Moreno, José M ^b,m  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c ASTRAZENECA   (United Kingdom)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY OF TROMSØ   (Norway)

^h UNIVERSIDAD DE MÁLAGA   (Spain)

ⁱ NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^j HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^k HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF VALENCIA   (Spain)

ⁿ JOHNS HOPKINS UNIVERSITY   (United States)

more..

Author keywords

Case control studies; Chromium; Metals, heavy; Myocardial infarction; Neutron activation analysis

Indexed keywords

CHROMIUM;

CHROMIUM; RISK FACTOR;

ACUTE HEART INFARCTION; ADULT; ANALYTIC METHOD; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHROMIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; INTENSIVE CARE UNIT; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS OF VARIANCE; NAIL BED; NEUTRON ACTIVATION ANALYSIS; PATIENT SELECTION; POPULATION EXPOSURE; POPULATION RESEARCH; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REGISTER; RISK ASSESSMENT; SAMPLE SIZE; CHEMISTRY; HEART INFARCTION; INTERNATIONAL COOPERATION; MIDDLE AGED; NAIL; RISK; RISK FACTOR; TOE;

CASE-CONTROL STUDIES; CHROMIUM; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NAILS; NEUTRON ACTIVATION ANALYSIS; RISK; RISK FACTORS; TOES;

EID: 23444455019     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwi180     Document Type: Article

References (44)

1. Stoecker BJ. Chromium. In: Shils ME, Olson JA, Shike M, et al, eds. Modem nutrition in health and disease. Baltimore, MD: Williams & Wilkins Company, 1999:277-82.
2. World Health Organization, International Atomic Energy Agency, and Food and Agriculture Organization of the United Nations. Trace elements in human nutrition and health. Geneva, Switzerland: World Health Organization, 1996.
3. Panel on Micronutrients, Food and Nutrition Board, National Academy of Sciences. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press, 2001.
4. Katz SA, Salem H. The biological and environmental chemistry of chromium. New York, NY: VCH Publishers, 1994.
5. Mertz W. Chromium in human nutrition: a review. J Nutr 1993;123:626-33.
6. Anderson RA. Chromium as an essential nutrient for humans. Regul Toxicol Pharmacol 1997;26:S35-41.
7. Vincent JB. Recent advances in the nutritional biochemistry of trivalent chromium. Proc Nutr Soc 2004;63:41-7.
8. Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care 2004;27:2741-51.
9. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr 1998;17:548-55.
10. Jeejeebhoy KN. Chromium and parenteral nutrition. J Trace Elem Exp Med 1999;12:85-9.
11. Anderson RA, Kozlovsky AS. Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am J Clin Nutr 1985;41:1177-83.
12. Simon HB. Patient-directed, nonprescription approaches to cardiovascular disease. Arch Intern Med 1994;154:2283-96.
13. Lukaski HC. Chromium as a supplement. Annu Rev Nutr 1999;19:279-302.
14. Vincent JB. The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent. Sports Med 2003;33:213-30.
15. Nissen SL, Sharp RL. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol 2003;94:651-9.
16. Pittler MH, Stevinson C, Ernst E. Chromium picolinate for reducing body weight: meta-analysis of randomized trials. Int J Obes Relat Metab Disord 2003;27:522-9.
17. Althuis MD, Jordan NE, Ludington EA, et al. Glucose and insulin responses to dietary chromium supplements: a meta-analysis. Am J Clin Nutr 2002;76:148-55.
18. Schroeder HA, Nason AP, Tipton IH. Chromium deficiency as a factor in atherosclerosis. J Chronic Dis 1970;23:123-42.
19. Newman HA, Leighton RF, Lanese RR, et al. Serum chromium and angiographically determined coronary artery disease. Clin Chem 1978;24:541-4.
20. Simonoff M. Low plasma chromium in patients with coronary artery and heart diseases. Biol Trace Elem Res 1984;6:431-9.
21. Kardinaal AF, Kok FJ, Ringstad J, et al. Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC Study. Lancet 1993;342:1379-84.
22. Kardinaal AF, Kok FJ, Kohlmeier L, et al. Association between toenail selenium and risk of acute myocardial infarction in European men: The EURAMIC Study. European Antioxidant Myocardial Infarction and Breast Cancer. Am J Epidemiol 1997;145:373-9.
23. Guallar E, Sanz-Gallardo MI, van 't Veer P, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 2002;347:1747-54.
24. Bode P, de Goeij JJM. Activation analysis. In: Meyers RA, ed. Encyclopedia of environmental analysis and remediation. New York, NY: John Wiley and Sons, Inc, 1998:68-84.
25. Bode P. Automation and quality assurance in the NAA facilities in Delft. J Radioanal Nucl Chem 2000;245:127-32.
26. Data Analysis and Products Division, MathSoft, Inc. S-Plus 2000 user's guide. Seattle, WA: MathSoft, Inc, 1999.
27. Rimm EB, Guallar E, Giovannucci E, et al. Toenail chromium levels and risk of coronary heart disease among normal and overweight men. (Abstract). In: Final Program and Abstracts of the 42nd Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Honolulu, Hawaii, April 23-26, 2002. Dallas, TX: American Heart Association, 2002:P151.
28. Rajpathak S, Rimm EB, Li T, et al. Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 2004;27:2211-16.
29. Davis CM, Vincent JB. Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 1997;36:4382-5.
30. Vincent JB. Mechanisms of chromium action: low-molecular-weight chromium-binding substance. J Am Coll Nutr 1999;18:6-12.
31. Morris BW, MacNeil S, Hardisty CA, et al. Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elem Med Biol 1999;13:57-61.
32. Department of Foods and Nutrition, American Medical Association. Guidelines for essential trace element preparations for parenteral use: a statement by an expert panel. JAMA 1979;241:2051-4.
33. Abraham AS, Sonnenblick M, Eini M, et al. The effect of chromium on established atherosclerotic plaques in rabbits. Am J Clin Nutr 1980;33:2294-8.
34. Abraham AS, Brooks BA, Eylath U. Chromium and cholesterol-induced atherosclerosis in rabbits. Ann Nutr Metab 1991;35:203-7.
35. Anderson RA, Bryden NA, Polansky MM. Dietary chromium intake: freely chosen diets, institutional diet, and individual foods. Biol Trace Elem Res 1992;32:117-21.
36. Kozlovsky AS, Moser PB, Reiser S, et al. Effects of diets high in simple sugars on urinary chromium losses. Metabolism 1986;35:515-18.
37. Offenbacher EG, Pi-Sunyer FX, Stoecker BJ. Chromium. In: O'Dell BL, Sunde RA, eds. Handbook of nutritionally essential mineral elements. New York, NY: Marcel Dekker, 1997: 389-411.
38. Pfeifer HR, Derron MH, Rey D, et al. Natural trace element input to the soil-sediment-water-plant system: examples of background and contaminated situation in Switzerland, eastern France and northern Italy. In: Markert B, Friese K, eds. Trace elements - their distribution and effects in the environment. Amsterdam, the Netherlands: Elsevier, 2000:33-86.
39. Anderson RA. Chromium. In: Mertz W, ed. Trace elements in human and animal nutrition. Orlando, FL: Academic Press, Inc, 1987:225-44.
40. Garland M, Morris JS, Rosner BA, et al. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 1993;2:493-7.
41. Davies S, McLaren HJ, Hunnisett A, et al. Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients - implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism 1997;46:469-73.
42. Veillon C, Patterson KY. Analytical issues in chromium research. J Trace Elem Exp Med 1999;12:99-109.
43. Anderson H, Morris JS. Contamination studies in the use of human nails for dietary studies: the effect of clippers. J Radioanal Nucl Chem 1992;158:251-9.
44. Frantzen K. Chromium. In: Harbison RD, Hardy HL, Hamilton A, eds. Hamilton and Hardy's industrial toxicology. 5th ed. St. Louis, MO: CV Mosby Company, 1998:51-4.